Guide to Drug Financing Mechanisms
(1998; 64 pages) [French] [Spanish]
Table des matières
Afficher le documentForeword
Afficher le documentAcknowledgements
Fermer ce répertoireIntroduction
Afficher le documentObjectives
Afficher le documentAudience
Afficher le documentConcepts
Afficher le documentPlan of this book
Ouvrir ce répertoire et afficher son contenuChapter 1. Selection
Ouvrir ce répertoire et afficher son contenuChapter 2. Procurement
Ouvrir ce répertoire et afficher son contenuChapter 3. Distribution
Ouvrir ce répertoire et afficher son contenuChapter 4. Prescribing
Ouvrir ce répertoire et afficher son contenuSummary: contributions and limitations of the economic approach
Afficher le documentReferences
Afficher le documentSelected WHO publications of related interest
Afficher le documentBack cover
 

Plan of this book

The topics discussed here are those to which economic methods are most relevant. Quantification has been studied in depth elsewhere (4). Utilization is an area of research that is now expanding fast (5). It is discussed here only with regard to the economic aspects of prescribing. The main aspects of pharmaceutical supply are therefore examined as follows: selection (Chapter 1), procurement (Chapter 2), distribution (Chapter 3), and prescribing (Chapter 4).

The links between the pharmaceutical supply system, the financing system and the information system are studied with regard to each aspect. Each is examined under three headings: What are the objectives? What processes allow these objectives to be attained? What structures and organizational arrangements are needed to carry out these processes and attain these objectives?

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013